t(11;19) (q23;p13.3); (MLL-ENL), PCR QUALITATIVE
Chromosomal rearrangements can produce tumorigenic fusion genes. This mechanism is seen in 15-25% of Leukemias, Lymphomas & Sarcomas. Fusions can be produced by translocations, inversions or deletions. Specific gene fusions in a patient's tumor cells have an important bearing on the management & prognosis. MLL fusion gene in Mixed lineage leukemias is observed with equal frequency in AML & ALL. It is a poor prognostic marker in ALL.
Parameter(s) covered : 1
Report Frequency: Sample Mon / Thu by 11 am; Report Wed / Sat
Special Instruction: Physician prescription is mandatory.
Price : ₹ 3500.00
Parameters
- t (11;19) (q23;p13.3); (MLL-ENL)